Earlier switching from intravenous to oral antibiotics owing to electronic reminders

被引:12
作者
Beeler, Patrick E. [1 ]
Kuster, Stefan P. [2 ,3 ,4 ]
Eschmann, Emmanuel [1 ]
Weber, Rainer [2 ,3 ,4 ]
Blaser, Juerg [1 ]
机构
[1] Univ Zurich, Univ Zurich Hosp, Res Ctr Med Informat, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Hosp Epidemiol, CH-8091 Zurich, Switzerland
[4] Univ Zurich, CH-8091 Zurich, Switzerland
关键词
Anti infective agents/administration & dosage; Decision support systems; clinical; Medical informatics; reminder systems; Antibacterial agents; COMMUNITY-ACQUIRED PNEUMONIA; CLUSTER RANDOMIZED-TRIAL; HOSPITALIZED-PATIENTS; INFECTIOUS-DISEASES; THERAPY; REASSESSMENT; IMPLEMENTATION; INTERVENTION; GUIDELINES; SOCIETY;
D O I
10.1016/j.ijantimicag.2015.06.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Paper-based interventions have been shown to stimulate switching from intravenous (i.v.) to oral (p.o.) antibiotic therapies. Shorter i.v. durations are associated with a lower risk of iatrogenic infections as well as reduced workload and costs. The purpose of this study was to determine whether automated electronic reminders are able to promote earlier switching. In this controlled before-and-after study, an algorithm identified patients who were eligible for i.v.-to-p.o. switch 60h after starting i.v. antimicrobials. Reminders offering guidance on the re-assessment of initial i.v. therapy were displayed within the electronic health records in 12 units during the intervention period (year 2012). In contrast, no reminders were visible during the baseline period (2011) and in the control group (17 units). A total of 22 863 i.v. antibiotic therapies were analysed; 6082(26.6%) were switched to p.o. therapy. In the intervention group, 757 courses of i.v. antibiotics were administered for a mean + standard deviation duration of 5.4 +/- 8.1 days before switching to p.o. antibiotics in the baseline period, and 794 courses for 4.5 +/- 5.5 days in the intervention period (P=0.004), corresponding to a 17.5% reduction of i.v. administration time. In contrast, in the control group the duration increased; 2240 i.v. antibiotics were administered for a mean duration of 4.0 +/- 5.9 days in the baseline period, and 2291 for 4.3 +/- 5.8 days in the intervention period (13= 0.03). Electronic reminders fostered earlier i.v.-to-p.o. switches, thereby reducing the duration of initial i.v. therapies by nearly a day. (C) 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:428 / 433
页数:6
相关论文
共 30 条
[1]   Effect of a 3-Step Critical Pathway to Reduce Duration of Intravenous Antibiotic Therapy and Length of Stay in Community-Acquired Pneumonia A Randomized Controlled Trial [J].
Carratala, Jordi ;
Garcia-Vidal, Carolina ;
Ortega, Lucia ;
Fernandez-Sabe, Nuria ;
Clemente, Mercedes ;
Albero, Ginesa ;
Lopez, Marta ;
Castellsague, Xavier ;
Dorca, Jordi ;
Verdaguer, Ricard ;
Martinez-Montauti, Joaquin ;
Manresa, Frederic ;
Gudiol, Francesc .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (12) :922-928
[2]   Different Patterns of Inappropriate Antimicrobial Use in Surgical and Medical Units at a Tertiary Care Hospital in Switzerland: A Prevalence Survey [J].
Cusini, Alexia ;
Rampini, Silvana K. ;
Bansal, Vineeta ;
Ledergerber, Bruno ;
Kuster, Stefan P. ;
Ruef, Christian ;
Weber, Rainer .
PLOS ONE, 2010, 5 (11)
[3]  
Davey P, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub3]
[4]   Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship [J].
Dellit, Timothy H. ;
Owens, Robert C. ;
McGowan, John E., Jr. ;
Gerding, Dale N. ;
Weinstein, Robert A. ;
Burke, John P. ;
Huskins, W. Charles ;
Paterson, David L. ;
Fishman, Neil O. ;
Carpenter, Christopher F. ;
Brennan, P. J. ;
Billeter, Marianne ;
Hooton, Thomas M. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :159-177
[5]   Seasonality of infectious diseases and severe acute respiratory syndrome - what we don't know can hurt us [J].
Dowell, SF ;
Ho, MS .
LANCET INFECTIOUS DISEASES, 2004, 4 (11) :704-708
[6]   Conversion from intravenous to oral medications - Assessment of a computerized intervention for hospitalized patients [J].
Fischer, MA ;
Solomon, DH ;
Teich, JM ;
Avorn, J .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (21) :2585-2589
[7]   Antibiotic optimization - An evaluation of patient safety and economic outcomes [J].
Fraser, GL ;
Stogsdill, P ;
Dickens, JD ;
Wennberg, DE ;
Smith, RP ;
Prato, BS .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (15) :1689-1694
[8]   The use and interpretation of quasi-experimental studies in infectious diseases [J].
Harris, AD ;
Bradham, DD ;
Baumgarten, M ;
Zuckerman, IH ;
Fink, JC ;
Perencevich, EN .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (11) :1586-1591
[9]   Unnecessary use of antimicrobials in hospitalized patients - Current patterns of misuse with an emphasis on the antianaerobic spectrum of activity [J].
Hecker, MT ;
Aron, DC ;
Patel, NP ;
Lehmann, MK ;
Donskey, CJ .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (08) :972-978
[10]   The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting [J].
Hemming, K. ;
Haines, T. P. ;
Chilton, P. J. ;
Girling, A. J. ;
Lilford, R. J. .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350